LACTATE DEHYDROGENASE 02P56-21

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional report with the FDA on 2016-09-06 for LACTATE DEHYDROGENASE 02P56-21 manufactured by Abbott Manufacturing Inc.

Event Text Entries

[54026339] Further investigation of the customer issue included a review of the complaint text, in-house testing, instrument log review, a search for similar complaints, and a review of labeling. Return material was made available. In house testing protocol was executed; the assay files for the reagent lot number was successfully calibrated and each validity control replicate generated was within the established ranges. It was determined the reagent lot is performing acceptably. The instrument logs did indicated that instrument error messages were generated on the customer analyzer. The error could indicate the presence of bubbles, foam or fibrin in the sample. Tracking and trending did not identify an adverse trend. Labeling was reviewed and found to be adequate. Based on the available information no malfunction and no product deficiency of the clinical chemistry lactate dehydrogenase assay, reagent list number 02p56-21 , lot number 25802un16 , were identified.
Patient Sequence No: 1, Text Type: N, H10


[54026340] The customer generated falsely elevated clinical chemistry ldh (lactate dehydrogenase) results. The customer indicated that a pregnant woman, 38+ weeks gestation, was admitted to the hospital and had her labor induced. The customer documented that the patient had hypertension and positive protein results in conjunction with the elevated ldh result. The customer provided the following ldh results: (b)(6) 2016: initial 1063 u/l, the patient was redrawn 12 hours later, (b)(6) 2016: 142. 4 u/l. The original specimen was retested on (b)(6) 2016: 363. 0 and 303 u/l. It is unknown whether the patient had pre-eclampsia therefore the induction may have been unnecessary. The mother is doing well and there were no complications documented regarding the delivery.
Patient Sequence No: 1, Text Type: D, B5


[73465471] Conclusion code changed from. The device evaluation was reassessed and concluded that a malfunction occurred. However, no systemic issue or product deficiency was identified for the lactate dehydrogenase, list number 02p56, lot 25802un16.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1628664-2016-00230
MDR Report Key5930753
Report SourceFOREIGN,HEALTH PROFESSIONAL
Date Received2016-09-06
Date of Report2017-04-23
Date of Event2016-08-03
Date Mfgr Received2017-04-17
Device Manufacturer Date2016-04-01
Date Added to Maude2016-09-06
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNOEMI ROMERO-KONDOS, RN BSN
Manufacturer Street100 ABBOTT PARK ROAD DEPT. 09B9, LCCP1-3
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone224667-512
Manufacturer G1ABBOTT MANUFACTURING INC
Manufacturer Street1921 HURD DRIVE
Manufacturer CityIRVING TX 75038
Manufacturer CountryUS
Manufacturer Postal Code75038
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameLACTATE DEHYDROGENASE
Generic NameLACTATE DEHYDROGENASE
Product CodeCFJ
Date Received2016-09-06
Catalog Number02P56-21
Lot Number25802UN16
Device Expiration Date2017-02-05
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerABBOTT MANUFACTURING INC
Manufacturer Address1921 HURD DRIVE IRVING TX 75038 US 75038


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2016-09-06

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.